企業プロフィール
IQVIA 株価・ニュース・カタリスト
- ティッカー:
- IQV
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
260.72 USD (-3.02%)
終値
最終更新: 2026年10月1日
30.1B USD
時価総額
株価変動の要因
2026年10月1日 時点で IQV は 3.02% 下落し、$260.72 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Life Sciences Data and Services Company
IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers. Its model combines global execution capabilities with large healthcare datasets, analytics, and technology.
Research and Development Solutions
Research and Development Solutions supports clinical trials from study design and site selection through patient recruitment, monitoring, data management, and regulatory submission. The business operates globally and generates substantial contracted backlog from multiyear development programs.
Commercial Solutions
Commercial Solutions provides market data, real-world evidence, consulting, technology, patient support, and commercial engagement services. Customers use these offerings to assess markets, plan launches, optimize field operations, and measure product performance.
Connected Intelligence Platform
IQVIA Connected Intelligence links proprietary data, healthcare-grade AI, advanced analytics, and domain expertise. The platform is designed to convert fragmented clinical and commercial information into decisions across drug development and commercialization.
Global Scale and Therapeutic Expertise
IQVIA operates in more than 100 countries with expertise spanning clinical operations, data science, technology, and healthcare markets. This scale allows the company to support multinational trials and commercial programs while adapting to local regulatory and privacy requirements.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。